# Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)

> **NCT00077051** · PHASE1 · COMPLETED · sponsor: **University of Miami** · enrollment: 1 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** cytochlor
- **DRUG:** tetrahydrouridine
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00077051
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2016-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077051, "Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00077051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*